<code id='5E195D13FB'></code><style id='5E195D13FB'></style>
    • <acronym id='5E195D13FB'></acronym>
      <center id='5E195D13FB'><center id='5E195D13FB'><tfoot id='5E195D13FB'></tfoot></center><abbr id='5E195D13FB'><dir id='5E195D13FB'><tfoot id='5E195D13FB'></tfoot><noframes id='5E195D13FB'>

    • <optgroup id='5E195D13FB'><strike id='5E195D13FB'><sup id='5E195D13FB'></sup></strike><code id='5E195D13FB'></code></optgroup>
        1. <b id='5E195D13FB'><label id='5E195D13FB'><select id='5E195D13FB'><dt id='5E195D13FB'><span id='5E195D13FB'></span></dt></select></label></b><u id='5E195D13FB'></u>
          <i id='5E195D13FB'><strike id='5E195D13FB'><tt id='5E195D13FB'><pre id='5E195D13FB'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:31
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In